- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03589612
Regression of Hamstring Flexibility and Performance in Children With Duchenne Muscular Dystrophy
September 27, 2019 updated by: Lütfiye AKKURT, PT, Hacettepe University
Investigator investigated that regression of hamstring flexibility and performance in children with Duchenne Muscular Dystrophy.
Study Overview
Status
Completed
Conditions
Detailed Description
Flexibility of hamstrings was evaluated by Popliteal Angle test.
Performance was evaluated 6 Minute Walk Test (6 MWT).
Regression of hamstring flexibility and performance was examined regression tests.
Correlation was examined between popliteal angle test and parameter of North Star Ambulation Assessment.
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sıhhiye
-
Ankara, Sıhhiye, Turkey
- Hacettepe University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 14 years (Child)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Male
Sampling Method
Probability Sample
Study Population
Sixty children will participated this study.
Fourty-two children was assessed, and eighteen children will assess in a few months.
Description
Inclusion Criteria:
- To be a Duchenne Muscular Dystrophy diagnosis,
- Being in the ambulatory period and climbing four steps independently,
- to be Level 1 and Level 2 according to Brooke Lower Functional Classification Test
- To be able to cooperate
- No any severe contracture in the lower limbs which may prevent assessments,
Exclusion Criteria:
- Children who fail to meet these criteria study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Popliteal Angle Test
Time Frame: 5 minute
|
The Popliteal Angle Test was used to assess hamstring flexibility.
Child asked to rise lower leg straight.
Incomplete angle degree of full extension is popliteal angle.
|
5 minute
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6 Minute Walk Test
Time Frame: 6 minute
|
6 Minute Walk Test was used to assess performance with children Duchenne MUscular Dystropy.
|
6 minute
|
North Star Ambulation Assessment
Time Frame: 20 minute
|
The North Star Ambulatory Assessment (NSAA) is used to assess mobility for in ambulatory children with DMD for 5 years.
NSAA is consist of 17 items from stand to run.
|
20 minute
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ayşe Karaduman, Prof., Hacettepe University
- Principal Investigator: İpek Gürbüz, Assoc.Prof., Hacettepe University
- Principal Investigator: Güllü Aydın, Msc., Hacettepe University
- Principal Investigator: Numan Bulut, Msc, Hacettepe University
- Study Director: Oznur Yılmaz, Hacettepe University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 8, 2018
Primary Completion (Actual)
January 24, 2019
Study Completion (Actual)
January 24, 2019
Study Registration Dates
First Submitted
July 5, 2018
First Submitted That Met QC Criteria
July 5, 2018
First Posted (Actual)
July 18, 2018
Study Record Updates
Last Update Posted (Actual)
September 30, 2019
Last Update Submitted That Met QC Criteria
September 27, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GO 16/740-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Performance
-
Atılım UniversityNot yet recruitingCognitive Performance | Physical PerformanceTurkey
-
PepsiCo Global R&DCompletedSkill Performance | Soccer Performance | Coffeeberry EffectsUnited Kingdom
-
PepsiCo Global R&DCompletedSleep | Cognitive Performance | Balance | Physical PerformanceAustralia
-
Universidade Federal de Santa CatarinaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.CompletedEndurance Performance | Sports Nutritional Sciences | Sports PerformanceBrazil
-
Maastricht University Medical CenterCompletedNitrate | Time-trial Performance | Submaximal Exercise Performance | NitriteNetherlands
-
Tehran University of Medical SciencesBiotechnology and Biological Sciences Research Council; Mazandaran University...Unknown
-
Florida State UniversityCompleted
-
University of ZurichSwiss Federal Institute of TechnologyCompletedPerformanceSwitzerland
-
Universidad Católica San Antonio de MurciaCompleted